Frances F. Townsend
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
FCX Grasberg on schedule amid cash flow valuation questions. Recent news highlights that Freeport-McMoRan's Grasberg operation is back on schedule, supporting its production outlook. However, market commentary questions whether the stock is priced for perfection on cash flow, with copper prices acting as a key test. The company's valuation of 33.9 times trailing earnings reflects high market expectations for cash flow delivery.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Chubb (CB) Q3 Earnings Outlook: Potential Beat Amid Guidance Concerns. Analysts note that Chubb is expected to post earnings above consensus estimates for the third quarter, driven by strong underwriting results and investment income. At the same time, a recent note points to softer EPS guidance and a new fee initiative that could temper optimism. The mixed signals suggest the upcoming report will be closely watched.
Transaction History
| DRS | ▲ Buy | Option Exercise | 1,006 | $0 | 9/30/2026 | View on chart |
| DRS | ▲ Buy | Option Exercise | 1,006 | $0 | 6/30/2026 | View on chart |
| DRS | ▲ Buy | Option Exercise | 3,556 | $0 | 6/4/2026 | View on chart |
| FCX | ▲ Buy | Grant | 2,800 | $0 | 6/1/2026 | View on chart |
| CB | ▲ Buy | Grant | 681 | — | 5/21/2026 | View on chart |
| CB | ▼ Sell | Tax Withholding | 193 | $64K | 5/21/2026 | View on chart |
| DRS | ▲ Buy | Option Exercise | 1,006 | $0 | 4/1/2026 | View on chart |
| FCX | ▲ Buy | Grant | 4,900 | $0 | 6/1/2025 | View on chart |
| DRS | ▲ Buy | Option Exercise | 6,438 | $0 | 5/15/2025 | View on chart |
| CB | ▼ Sell | Tax Withholding | 180 | $53K | 5/15/2025 | View on chart |
| CB | ▲ Buy | Grant | 771 | — | 5/15/2025 | View on chart |
| DRS | ▲ Buy | Option Exercise | 3,572 | $0 | 11/29/2024 | View on chart |
| DRS | ▲ Buy | Option Exercise | 9,785 | $0 | 6/1/2024 | View on chart |
| FCX | ▲ Buy | Grant | 3,500 | $0 | 6/1/2024 | View on chart |
| CB | ▲ Buy | Grant | 718 | — | 5/16/2024 | View on chart |
| CB | ▼ Sell | Tax Withholding | 239 | $63K | 5/16/2024 | View on chart |
| DRS | ▲ Buy | Option Exercise | 3,571 | $0 | 11/29/2023 | View on chart |
| FCX | ▲ Buy | Grant | 5,000 | $0 | 6/1/2023 | View on chart |
| CB | ▼ Sell | Tax Withholding | 233 | $46K | 5/17/2023 | View on chart |
| CB | ▲ Buy | Grant | 955 | — | 5/17/2023 | View on chart |
| DRS | ▲ Buy | Option Exercise | 6,954 | $0 | 5/15/2023 | View on chart |
| FCX | ▲ Buy | Grant | 4,500 | $0 | 6/1/2022 | View on chart |
| CB | ▲ Buy | Grant | 932 | — | 5/19/2022 | View on chart |
| CB | ▼ Sell | Tax Withholding | 271 | $55K | 5/19/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Leonardo DRS Sets Q3 2026 Earnings Call Date
Leonardo DRS has scheduled its third-quarter 2026 earnings conference call for October 29, 2026. This standard corporate announcement coincides with recent analyst notes describing the company as having affordable growth and neutral valuation. The stock is currently trading with an RSI of 38.2, which is below the neutral 50 mark, while the average analyst target price sits at $53.82.
Leonardo DRS Sets Q3 2026 Earnings Call Date. Leonardo DRS has scheduled its third-quarter 2026 earnings conference call for October 29, 2026. This standard corporate announcement coincides with recent analyst notes describing the company as having affordable growth and neutral valuation. The stock is currently trading with an RSI of 38.2, which is below the neutral 50 mark, while the average analyst target price sits at $53.82.